MyFinsight
Home
Blog
About
Contact
Download
Download image
Maturities of marketable
debt securities
$108,178K
Other
-$48K
Net cash provided by
(used in) investing...
$23,132K
Canceled cashflow
$85,094K
Net decrease in
cash, cash...
-$23,702K
Canceled cashflow
$23,132K
Purchases of marketable
debt securities
$83,161K
Purchases of property and
equipment
$1,933K
Net cash used in
operating activities -...
-$46,686K
Effect of foreign
exchange rates on cash and...
-$129K
Net cash used in
financing activities
-$19K
Stock-based compensation
$15,853K
Depreciation and
amortization
$12,799K
Non-cash lease expense
$7,114K
Change in fair value of
notes receivable
-$6,759K
Prepaid expenses and
other current assets
-$5,930K
Loss on investments
-$939K
Other non-cash
activity
-$185K
Other non-current
assets
-$94K
Net cash used in
operating activities -...
-$46,433K
Net cash used in
operating activities -...
-$253K
Canceled cashflow
$49,673K
Principal payments on
finance leases
$19K
Net loss from
continuing operations
-$76,059K
Accounts payable,
accrued expenses and...
-$11,601K
Operating lease
liabilities, current and...
-$4,995K
Deferred revenue
-$2,606K
Other non-current
liabilities
-$758K
Changes in operating
assets and liabilities
$242K
Back
Back
Cash Flow
Ginkgo Bioworks Holdings, Inc. (DNABW)
Ginkgo Bioworks Holdings, Inc. (DNABW)
source: myfinsight.com